Loading
Latest filing published 18 Jan 2019 for TETRAPHASE PHARMACEUTICALS INC.
No signal scores available.
Larry Tsai appears in our data through filings on Tetraphase Pharmaceuticals Inc shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 14 May 2018 to 6 January 2019.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 18 January 2019 came the latest disclosure, a share grant in Tetraphase Pharmaceuticals Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations